SEC Form 4 · accession 0001253820-26-000005
Fulgent Genetics, Inc. · FLGT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Kim
Officer — CFO and Treasurer
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 5:29 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001674930
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2026 | F | 2,087 | $18.09 | D | 362,545 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025.